National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018

Size: px
Start display at page:

Download "National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018"

Transcription

1 National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018 The NHMRC has publically released results (embargo lifted on 11 October 2017) for the Early Career Fellowships, Practitioner Fellowships, Research Fellowships and Australia/European Union Collaborative Research Grants Scheme for funding in For this round, across the sector: 472 applications were submitted to the Early Career Fellowships Scheme. 120 were funded with a success rate of 25.4% and total funding of $38,526,110 was awarded. 388 applications were submitted to the Career Development Fellowships scheme. 61 were funded with a success rate of 15.7% and total funding of $26,660, applications were submitted to the Research Fellowships Scheme. 76 were funded with a success rate of 23.6% and total funding of $57,738,355 was awarded. 71 applications were submitted to the Practitioner Fellowships Scheme. 16 were funded with a success rate of 22.5% % and total funding of $7,724,511 was awarded 4 applications were submitted to the Australia/European Union Collaborative Research Grant Scheme. 4 were. awarded with total funding of $1,902,628 For this round, James Cook University: 1 5 Early Fellowships. 1 was awarded at $317,768 over 4 years 4 Career Development Fellowships. 2 were awarded at $862,000 over 4 years 4 Research Fellowships. 1 was awarded at $849,540 over 5 years No Practitioner Fellowships were submitted in this round 1 Australia/European Union Collaborative Research Grant Scheme. 1 was awarded at $488,914 over 2 years TOTAL FUNDS AWARDED TO JCU $2,518,222

2 Details of successful James Cook University fellowships: Early Career Fellowships Scheme App Id Chief Investigator Title $ Dr Matt Developing Core Bioinformatics $318,768 Field Capacity at AITHM Dr Matt Field Developing Core Bioinformatics Capacity at AITHM $318,768 over 4 years Cost effective next generation sequencing is now a reality, meaning the bottleneck for research projects has shifted from data generation to data analysis. Researchers at the Australian Institute of Health and Tropical Medicine (AITHM) are engaged in an increasing number of high-impact research projects that require timely access to high-throughput bioinformatics best-practices methodologies. This proposal outlines strategies to develop support for projects requiring bioinformatics within AITHM. Career Development Fellowships Dr Andreas New strategies for improved TB $431,000 Kupz vaccines Dr Andreas Kupz New strategies for improved TB vaccines $431,000 over 4 years Tuberculosis is a major global public health problem and continues to cause significant morbidity and mortality due to the low efficiency of the only licensed anti-tuberculosis vaccine, BCG. This project aims to produce novel, highly efficacious vaccination regimens against tuberculosis, especially pulmonary tuberculosis, which is currently the most difficult manifestation of infection to control. The results of this project have the potential to not only save millions of lives in the developing world but also to decrease socioeconomic burden of tuberculosis, particularly in the context of HIV coinfection Prof Stephan Karl Unravelling Plasmodium vivax transmission to mosquitoes $431,000 Professor Stephan Karl Unravelling Plasmodium vivax transmission to mosquitoes $431,000 over 4 years This project is aimed at better understanding transmission of P. vivax, the world s most widely spread malaria parasite. Using a newly established experimental platform that enables us to feed P. vivax infected blood to Anopheles farauti mosquitoes, we can start researching factors in human blood that determine P. vivax infection success, test new vaccine and drug candidates for their ability to block transmission and thus significantly advance science surrounding this neglected parasite. 2 Research Fellowships Prof Denise Doolan System-based approaches to inform the design of immunotherapies and immunodiagnostics against chronic pathogens $849,540 Professor Denise Doolan System-based approaches to inform the design of immunotherapies and immunodiagnostics against chronic pathogens $849,540 over 5 years

3 The development of effective interventions against malaria and other chronic infectious diseases is impeded by a lack of understanding of host-pathogen interactions and the mechanisms and antigenic targets underlying protective immunity. The fundamental premise of this proposal is that integrated and unbiased systems-level approaches provide an excellent framework to develop a comprehensive understanding of immune responses and identify key molecules/pathways that can be targeted for therapeutic intervention or for immunodiagnostics. Taking advantage of unique human experimental infection models and field studies, this research encompasses: (i) antigen discovery; (ii) hostpathogen immunity; (iii) vaccine engineering; and (iv) biomarker discovery. It will develop a pipeline of parasite antigens and immunomodulatory molecules that can be transitioned towards clinical development and testing, as well as identify biomarkers of disease risk that can be used for population based screening to define at-risk individuals for targeted intervention. Practitioner Fellowships Nil Australia/European Union Collaborative Research Grant Prof Denise Doolan OptiMalVax: Optimising a deployable high efficacy malaria vaccine $488,914 Professor Denise Doolan OptiMalVax: Optimising a deployable high efficacy malaria vaccine $488,914 over 2 years This project takes advantage of new vaccine technologies and antigen discovery approaches for accelerated design and development of a highly effective multi-antigen multi-stage subunit vaccine against malaria. A consortium comprising key malariologists, vaccine researchers and product developers in Europe, USA, Australia and Africa are collaborating in an innovative programme of antigen discovery science linked to rapid clinical development of new vaccine candidates. The workplan directly addresses tough problems in malaria vaccine design such as antigen choice and polymorphism as well as vaccine immunogenicity, efficacy, and durability, and employs stringent infectious challenges and functional assays to ensure biologically relevant outcomes. 3

4 Analysis of JCU activity over last rounds: Early Career Fellowships Amount$ $318,768 $318,768 0 $309,436 $609,192 JCU % 20.0% 33% 0 20% 40% NHMRC % 25.4% 24.1% 21.4% 22.4% 24.5% Career Development Fellowships Amount$ $862,000 $569, JCU % 50% 100% % 15.7% 13.3% 29.4% 29.8% 28.1% Research Fellowships Amount$ $849,540 $938, JCU % 25% 25% NHMRC % 23.6% 26.1% 24.1% 30.1% 32.4% 4 Practitioner Fellowships Amount$ 0 $569, JCU % 0 100% NHMRC % % 29.4% 29.8% 28.1%

5 Aust/European Union 1 Amount$ $488,914 JCU % 100% NHMRC % First Call for the scheme 1 100% 5

6 s Comparisons for IRU and Go8 for this round (2017 Fellowships): EARLY CAREER FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University % $318,768 Charles Darwin University Flinders University Griffith University % $637,536 La Trobe University % $1,552,579 Murdoch University % $318,768 Western Sydney University Group of Eight (Go8) Go8 University of Adelaide % $3,812,448 Australian National University University of Melbourne % $4,000,694 Monash University % $5,215,766 University of New South Wales % $4,816,382 University of Queensland % $3,118,296 University of Sydney % $4,290,600 University of Western Australia % $1,606,210 6

7 CAREER DEVELOPMENT FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University % $862,000 Charles Darwin University Flinders University Griffith University La Trobe University Murdoch University Western Sydney University Group of Eight (Go8) Go8 University of Adelaide % $431,000 Australian National University % $476,728 University of Melbourne % $5,303,350 Monash University % $2,723,184 University of New South Wales % $5,061,096 University of Queensland % $1,338,728 University of Sydney % $2,741,475 University of Western Australia % $431,000 7

8 RESEARCH FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University % $849,540 Charles Darwin University Flinders University Griffith University % $1,556,910 La Trobe University % $782,370 Murdoch University Western Sydney University Group of Eight (Go8) Go8 University of Adelaide Australian National University % $2,197,120 University of Melbourne % $8,983,580 Monash University % $8,141,880 University of New South Wales % $3,274,625 University of Queensland % $4,985,915 University of Sydney % $5,682,505 University of Western Australia % $1,280,420 8

9 PRACTITIONER FELLOWSHIPS Innovative Research Universities (IRU) IRU Member James Cook University Charles Darwin University Flinders University Griffith University La Trobe University Murdoch University Group of Eight (Go8) Go8 University of Adelaide % $577,189 Australian National University University of Melbourne % $1,058,344 Monash University % $975,889 University of New South Wales University of Queensland University of Sydney % $2,322,898 University of Western Australia % $577,189 9

Copenhagen, Denmark, September August Malaria

Copenhagen, Denmark, September August Malaria Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support

More information

Dental Practitioner Programs Currently Accredited by the ADC

Dental Practitioner Programs Currently Accredited by the ADC Dental Practitioner Programs Currently Accredited by the ADC (as at 18 May 2017 contact the ADC for any updated information) Please note that graduates of programs accredited by the Australian Dental Council

More information

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated)

Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated) Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated) 07:00am - 07:55am (0:55) 08:00am - 08:45am (0:45) 08:50am - 09:20am (0:30) Chair: A/Prof Peter

More information

Dental Practitioner Programs Currently Accredited by the ADC

Dental Practitioner Programs Currently Accredited by the ADC Dental Practitioner s Currently Accredited by the ADC (as at 11 May contact the ADC for any updated information) Please note that graduates of programs by the n Dental Council (ADC) and approved by the

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

EC research and innovation strategy and actions

EC research and innovation strategy and actions EC research and innovation strategy and actions for preparedness and response to outbreaks IMI Stakeholder Forum 28-29 September 2016 Line Matthiessen Head of Unit E.3 Health Directorate DG Research &

More information

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity Developing the next generation of infection and immunity leaders The Peter Doherty Institute for Infection and Immunity Nobody can decide to discover something, but there are ways of making a discovery

More information

Understanding vaccine development

Understanding vaccine development Understanding vaccine development Firdausi Qadri Director, Centre for Vaccine Sciences International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Outline of this talk 1. Understanding disease

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

The EU strategy in Horizon2020 to fight poverty related diseases

The EU strategy in Horizon2020 to fight poverty related diseases Meeting on EDCTP2 French Ministry of Education, Science and Innovation, Paris 30 June 2017 The EU strategy in Horizon2020 to fight poverty related diseases Line Matthiessen Acting Director Health Directorate

More information

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 Introduction The Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030 provides an overarching policy framework

More information

SAMRC S RESPONSE TO HIV & TB: WALKING THE TALK: MOVING TO CONTROL

SAMRC S RESPONSE TO HIV & TB: WALKING THE TALK: MOVING TO CONTROL SAMRC S RESPONSE TO HIV & TB: WALKING THE TALK: MOVING TO CONTROL Glenda Gray President & CEO SAMRC 1 SA AIDS 2017 Durban 15 June 2017 Partner logo LEADERSHIP IN A TIME OF UNCERTAINTY 2 BASELINE BUDGET

More information

Overall presentation of IVR Strategy

Overall presentation of IVR Strategy Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research

More information

Dental Practitioner Programs Currently Accredited by the ADC

Dental Practitioner Programs Currently Accredited by the ADC Dental Practitioner s Currently Accredited by the ADC (as at 10 August contact the ADC for any updated information) Please note that graduates of programs by the n Dental Council (ADC) and approved by

More information

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap Background to development of vaccine roadmaps, to include priority areas for research, product development, capacities, and policy and commercialization Roadmaps as a Vehicle for Addressing Large- Scale

More information

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director Global health and vaccination: TB & beyond Dr Mary Moran Executive Director mmoran@policycures.org Outline About Policy Cures 3 reasons to focus on vaccine innovation Where are we today? The pipeline Where

More information

EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission

EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission EU support to hepatitis research Anna Lönnroth Sjödén Health Research DG Research - European Commission Hepatitis B and C Summit, Brussels, 15 October 2010 1 Main Objectives: to improve quality of life

More information

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed

More information

Horizon Introduction. Alex Harris Medical Research Council

Horizon Introduction. Alex Harris Medical Research Council Horizon 2020 - Introduction Alex Harris Medical Research Council Agenda MRC and Horizon 2020 UK Success Rate (FP7 Health) What is Horizon 2020? The Horizon 2020 Health Challenge NCP support MRC and Horizon

More information

The Burden of TB in the Population under the Partnership in Health Project

The Burden of TB in the Population under the Partnership in Health Project The Burden of TB in the Population under the Partnership in Health Project Suparat Phuanukoonnon PNGIMR, Madang Walter & Eliza Hall Institute AITHM, James Cook University Background Tuberculosis (TB) is

More information

the Office of Research Application Portal: Materials to submit:

the Office of Research Application Portal:   Materials to submit: Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due

More information

Intervention thematic group strategic portfolio

Intervention thematic group strategic portfolio Intervention thematic group strategic portfolio Stakeholders meeting 31 st January 2013 White Sands Hotel intv@ihi.or.tz Description of the Thematic Group Focuses on human populations Individually and

More information

Letter from the CEO. Dear Friends of IAVI,

Letter from the CEO. Dear Friends of IAVI, IAVI Annual Report 2017 Letter from the CEO Dear Friends of IAVI, We are pleased to present an overview of the progress IAVI and partners have made in 2017 toward our pursuit of the development of vaccines

More information

Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women

Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development for African pregnant women 7 th MIM Pan African Malaria Conference 15-20 April 2018 Dakar, Senegal The power of sharing science EDCTP session on Malaria in pregnancy programmes: challenges and priorities in antimalarial drug development

More information

1 introduction strengthening and ac- celerating future vaccine innovation and development for diseases of poverty.

1 introduction strengthening and ac- celerating future vaccine innovation and development for diseases of poverty. European Vaccine Initiative 1 Introduction Infectious diseases are key contributors to the devastating poverty in much of the world today. Every year diseases of poverty kill almost 9 million people, many

More information

DTA3/COFUND Programme Research Project Proforma

DTA3/COFUND Programme Research Project Proforma Page 1 General Information Project Code Partner University Faculty/School/Department/Research Centres First supervisor Please provide name and weblink Second supervisor Please provide name and weblink

More information

JOINING FORCES COLLABORATING WITH PARTNERS Annual Report

JOINING FORCES COLLABORATING WITH PARTNERS Annual Report 2016 Annual Report JOINING FORCES COLLABORATING WITH PARTNERS As a product development partnership, TB Alliance works with a wide variety of partners to advance TB drug development in the most efficient

More information

The Western Pacific Region faces significant

The Western Pacific Region faces significant COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

NIAID GL OBAL HEAL TH RESEAR CH PL AN FOR HIV/AIDS, MAL ARIA, AND TUBER CUL OSIS

NIAID GL OBAL HEAL TH RESEAR CH PL AN FOR HIV/AIDS, MAL ARIA, AND TUBER CUL OSIS NIAID GL OBAL HEAL TH RESEAR CH PL AN FOR HIV/AIDS, MAL ARIA, AND TUBER CUL OSIS M a y 7, 2 0 0 1 NA TIONAL INSTITUTE OF ALLER GY AND INFECTIOUS DISEASES NA TIONAL INSTITUTES OF HEAL TH U.S. DEP AR TMENT

More information

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

UNRAVELING THE MYSTERY BEHIND HIV/AIDS PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise

More information

Malaria Vaccine Pipeline

Malaria Vaccine Pipeline Malaria Vaccine Pipeline Perspectives and Challenges Carla Botting World Vaccine Congress Asia 2008 3 June 2008 Discussion Points Scope of the problem: the burden and challenge of malaria Malaria vaccine

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

The Global Fund & UNICEF Partnership

The Global Fund & UNICEF Partnership The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and

More information

GUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS

GUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS 1 Committee of Deans of Australian Medical Schools GUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS Prepared by Dr Philip Jones, UNSW, and Danielle Brown, CDAMS Overview These

More information

Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers

Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers Friday 13 February 2009, 0900 16:30 Holme Building, Science Rd, University of Sydney 9:00 9:15 Welcome Prof.

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

Finding the missing TB cases

Finding the missing TB cases Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working

More information

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative

The Value of Product Development Partnerships in Vaccine Innovation. Hansi J. Dean International AIDS Vaccine Initiative The Value of Product Development Partnerships in Vaccine Innovation Hansi J. Dean International AIDS Vaccine Initiative The Product Development Partnership Model A non-profit partnership of public and

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

Product Development for Vaccines Advisory Committee:

Product Development for Vaccines Advisory Committee: Product Development for Vaccines Advisory Committee: Highlights from the 2016 year of vaccine development SAGE, October 2016 David C. Kaslow, MD Chair, Product Development for Vaccines Advisory Committee

More information

TB Vaccine Development Strategy Overview

TB Vaccine Development Strategy Overview TB Vaccine Development Strategy Overview October 28, 2014 Angeline Nanni, MBA, MS Aeras Director, Global Access TB is Mother Nature s number one killer over the past centuries TB is spread through the

More information

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Version for the Silent Procedure 29 April Agenda item January Hepatitis Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh

More information

DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TROPICAL INFECTIOUS DISEASES SECOND EDITION PDF EBOOK EPUB MOBI Page 1 Page 2 tropical infectious diseases second edition tropical infectious diseases second pdf tropical infectious

More information

Rural and remote health care research funding at NHMRC opportunities and barriers

Rural and remote health care research funding at NHMRC opportunities and barriers and remote health care research funding at NHMRC opportunities and barriers Dr Timothy Dyke Strategic Policy Group 2 September 2014 Presentation Outline NHMRC strategies NHMRC funding of rural and remote

More information

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6

malaria epidemics FD90C2A80F37419F A1B6C58 Malaria Epidemics 1 / 6 Malaria Epidemics 1 / 6 2 / 6 3 / 6 Malaria Epidemics WHO/HTM/RBM/2003.49 Part II Prevention and control of Tutor's Guide World Health Organization HIV/AIDS, Tuberculosis and Malaria Prevention and control

More information

Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network:

Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network: Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network: Pregnant Women in the NIAID HIV/AIDS Clinical Trials Network Recompetition Carl W. Dieffenbach, Ph.D. Director Division

More information

Updating the Malaria Vaccine Technology Roadmap

Updating the Malaria Vaccine Technology Roadmap Updating the Malaria Vaccine Technology Roadmap Vasee Moorthy MRCP PhD MPAC 14 March 2013 Purpose of this MPAC session MPAC to be updated on the strategic R&D framework for malaria vaccines, including

More information

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS

ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS ENHANCING AFRICA S PUBLIC HEALTH RESPONSE THROUGH INNOVATION AND PARTNERSHIPS Strategic plan for the Africa CDC March 24-25, 2017 The Ebola outbreak underscored the fact that 2 pandemics are not just a

More information

Gesundheit in Horizont 2020

Gesundheit in Horizont 2020 Wien, 5, Dezember 2013 Gesundheit in Horizont 2020 Gesellschaftliche Herausforderung 1: Gesundheit, demografischer Wandel und Wohlergehen Dr Elmar Nimmesgern GD Forschung und Innovation Europäische Kommission

More information

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW TOWARDS AN CURE PEOPLE FOCUSED SCIENCE DRIVEN JULY 2018 A GLOBAL STRATEGIC APPROACH TOWARDS

More information

The Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong

The Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong The Influence of Climate Change on Insect Borne Diseases (1) Professor Martyn Jeggo Professor Martyn Jeggo Director Australian Animal Health Laboratory, Geelong The problem the risk of infectious disease

More information

IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting

IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting IHI Biomedical Sciences Group Joseph Mugasa, PhD, PD Stakeholders Meeting Jan 2013 Overview Biomedical group carries out a range of laboratory studies with the aim of understanding the pathogenesis, diagnosis

More information

Dentist labour force projections,

Dentist labour force projections, AIHW Dental Statistics and Research Unit Research Report No. 43 Dentist labour force projections, 200 2020 This report provides dentist labour force projections from 200 to the year 2020. In 2007 the establishment

More information

Update on TB Vaccines

Update on TB Vaccines Update on TB Vaccines Hennie Geldenhuys 11 May 2012 A safe and effective TB Vaccine within a decade A Strategic Blueprint for the Next Decade Tuberculosis, Vol 92, March 2012, Suppl. 1, pgs S1-S35 On

More information

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working

More information

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations

More information

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme Global Reporting System for Hepatitis (GRSH) An introduction WHO Global Hepatitis Programme 2018 Objectives 1. Explain the role of the new reporting system 2. Outline the reporting required from countries

More information

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus Digestive

More information

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

TRANS-NIH PLAN FOR HIV RELATED RESEARCH National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office

More information

High Level Across Sector Support to Implement the Three Plans South Australian Aboriginal Chronic Disease Consortium Goal Vision

High Level Across Sector Support to Implement the Three Plans South Australian Aboriginal Chronic Disease Consortium Goal Vision Now I live my life like there s no tomorrow. I live for my children and I live for my family. It has been twenty years since my diagnosis with testicular cancer. I can truly say that I won the race and

More information

Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas

Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations Malaria: A Review Malaria is a disease caused by a parasite of the genus Plasmodium. More than 150 species of Plasmodium

More information

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people

More information

Malaria Information & Prevention

Malaria Information & Prevention www.pammies.com Article Title: Malaria Information & Prevention (PDF) Malaria Information & Prevention AUTHOR P R HILL Cover Page Contents Tropical Parasitic Disease...2 The Symptoms...2 Malaria Medication...3

More information

Our T cell epitope test service offers you:

Our T cell epitope test service offers you: Our T cell epitope test service offers you: high throughput peptide discovery fast lead-finding maximum of epitopes in a minimum of blood saving effort and costs on developing your own platforms custom-made

More information

Innovation, Access and Delivery for Universal Health Coverage

Innovation, Access and Delivery for Universal Health Coverage A side event at the UHC Forum Co-hosted by UNDP and the GHIT Fund Tokyo, Japan 12 December 2017 Innovation, Access and Delivery for Universal Health Coverage From Innovation & Inequality, a UNDP-supported

More information

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022 UNHLM ON TB KEY TARGETS FOR 2022 WE, HEADS OF STATE AND GOVERNMENT AND REPRESENTATIVES OF STATES AND GOVERNMENTS ASSEMBLED AT THE UNITED NATIONS

More information

Children s Cancer Institute Strategic Plan It s not if. It s when. STRATEGIC PLAN

Children s Cancer Institute Strategic Plan It s not if. It s when. STRATEGIC PLAN Children s Cancer Institute Strategic Plan 2018-2022 It s not if. It s when. STRATEGIC PLAN 2018 2022 We can and will cure childhood cancer in the foreseeable future. PROFESSOR MICHELLE HABER AM EXECUTIVE

More information

HIV/AIDS in East Asia

HIV/AIDS in East Asia HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women

More information

7. Are you currently engaged in research that could support new TB diagnostic assay development? Yes No

7. Are you currently engaged in research that could support new TB diagnostic assay development? Yes No Determining Future TB Reference Material Requirements WHO/TDR TB Expert & End-User Survey Properly handled samples from well-characterized patients with suspected tuberculosis from disease endemic countries

More information

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014

EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014 EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014 EU Horizon 2020 for 2014-2020 In current prices nearly 80 billion; in constant prices

More information

Stakeholders meeting on Malaria

Stakeholders meeting on Malaria Plans and progress towards EDCTP2 Stakeholders meeting on Malaria 19 September 2013 Austrian Ministry of Science and Research First district of Vienna, Freyung 3, Vienna, Austria. Michael Makanga, MD PhD.

More information

Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT)

Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT) Press Release: Embargo in place until Monday, February 19 th, 2018 I 6:00 Eastern standard Time (11GMT) Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies

More information

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges

Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation European efforts in Mental Health research Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation European Commission Conference on Psychotherapy in Europe EP, Brussels 9 February 2012

More information

Identification of vaccine candidate antigens for a Babesia bovis transmission blocking vaccine

Identification of vaccine candidate antigens for a Babesia bovis transmission blocking vaccine Identification of vaccine candidate antigens for a Babesia bovis transmission blocking vaccine Carlos E. Suarez Animal Disease Research Unit ARS-USDA Department of Veterinary Microbiology and Pathology

More information

Kato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1

Kato, N. et al, Nature, 2016, Accelerated Article Preview. Celeste Alverez Current Literature 9/10/ /10/2016 Celeste Wipf Group 1 Kato, N. et al, Nature, 2016, Accelerated Article Preview Celeste Alverez Current Literature 9/10/2016 9/10/2016 Celeste Alverez @ Wipf Group 1 Malaria Caused by Plasmodium parasites Carried by 30-40 species

More information

Policy Document. Tobacco Free Campuses Policy. Background

Policy Document. Tobacco Free Campuses Policy. Background Policy Document Tobacco Free Campuses Policy Background The Australian Medical Students Association (AMSA) is the peak representative body for all medical students in Australia. AMSA believes that all

More information

Global progress in vaccine development

Global progress in vaccine development Global progress in vaccine development Helen McShane The Jenner Institute University of Oxford helen.mcshane@ndm.ox.ac.uk Vaccination The most cost-effective health intervention Smallpox Poliomyelitis

More information

Dr Graeme Suthers: The genetic basis of cancer

Dr Graeme Suthers: The genetic basis of cancer Dr Graeme Suthers: The genetic basis of cancer Dr Suthers is the head of the Familial Cancer Unit at the Women s and Children s hospital. He will begin the evening with an introduction to cancer and its

More information

Translating Duke Health. Accelerating discovery and its translation

Translating Duke Health. Accelerating discovery and its translation Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,

More information

Human Health Using nuclear techniques to improve health around the world

Human Health Using nuclear techniques to improve health around the world Human Health Using nuclear techniques to improve health around the world With its wide range of activities and expertise in nuclear science and medicine, the IAEA is helping Member States use nuclear techniques

More information

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where

More information

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework

Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework Latent TB Infection in the WHO European Region and recommendations on LTBI s M&E framework 18 th Wolfheze workshops / 15 th NTP managers meeting, 31 May 02 June 2017 Dr Andrei DADU Technical officer, Joint

More information

Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System

Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System Aleece MacPhail Alfred Health University of Melbourne Monash University

More information

award M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens Mireia Coscolla

award M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens Mireia Coscolla award M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens Mireia Coscolla Lausanne 16.06.2016 TB today TB is the 2nd bigest killer disease.6

More information

Global dengue situation and strategy for prevention and control ALERT AND RESPONSE OPERATIONS

Global dengue situation and strategy for prevention and control ALERT AND RESPONSE OPERATIONS Global dengue situation and strategy for prevention and control 2012-2020 ALERT AND RESPONSE OPERATIONS Global Dengue Risk 2012. Simmons CP et al. N Engl J Med 2012;366:1423-1432 Average /number of Dengue

More information

Consultation on proposed changes to prescribed qualifications

Consultation on proposed changes to prescribed qualifications 11 July 2016 Dear practitioner Consultation on proposed changes to prescribed qualifications The Dental Council (the Council) has undertaken educational reviews of two dental specialist programmes during

More information

Epidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM

Epidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM Epidemiology of chronic diseases in developing countries Prof Isaac Quaye, UNAM SOM Synopsis Definitions: epidemiology/chronic disease Changing trends in disease epidemiology towards non communicable Core

More information

ACCEPTED. Diseases, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia

ACCEPTED. Diseases, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia The Pediatric Infectious Disease Journal Publish Ahead of Print DOI : 10.1097/INF.0000000000000671 Plasmodium vivax malaria: challenges in diagnosis, treatment, and elimination James G Beeson 1,2, Cindy

More information

Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee Horizon 2020 - societal challenge 1 Health, demographic change and wellbeing Work Programme 2014-2015 Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee HORIZON 2020 Work Programmes

More information

Childhood Vaccination and Immunisation

Childhood Vaccination and Immunisation DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:

More information

FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY PROCEEDINGS. 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany

FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY PROCEEDINGS. 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany PROCEEDINGS Organization and Graphic project by: INTRODUCTION GLYCOVAX

More information

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS

More information

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION

GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION GUIDELINES, STATEMENTS & STANDARDS ON TUBERCULOSIS [AS OF NOVEMBER 2004] PART I. GROUPED BY AGENCY/ORGANIZATION Agency/Organization Name of the Guide/Statement Available at World Health Organization 1

More information

Communicable Disease Control And Health Protection Handbook Third Edition

Communicable Disease Control And Health Protection Handbook Third Edition Communicable Disease Control And Health Protection Handbook Third Edition Welcome to The Australian Immunisation Handbook 10th Edition website. and 6 months of age provided 76 to 80% protection from prolonged

More information

Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012,

Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012, Harnessing the Cooperative Advantage to Build a Better World, Global Forum on Cooperatives, UNDESA, Addis Ababa, 4 6 September 2012, UN African Union Social Development Policies: Implementation Challenges

More information

A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT. Introducing the Gates Medical Research Institute

A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT. Introducing the Gates Medical Research Institute A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT Introducing the Gates Medical Research Institute MY JOURNEY A NEW PARADIGM FOR TRANSLATIONAL VACCINE DEVELOPMENT Introducing the Gates Medical Research

More information

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 6//26 Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 27-24 Eric P.F. Chow,2, Denton Callander 3,4, Christopher K Fairley,2, Lei Zhang,2, Basil

More information